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Quantitative Sonographic Parameters as a 
Means of Distinguishing Breast Cancers 
from Benign Solid Breast Masses 
Dorit D. Adler, MD, Donna L. Hyde, BS, Debra M. Ikeda, MD 
Ultrasound examinations of solid breast masses were 
reviewed retrospectively to determine whether quan-
titative data of their dimensions could distinguish be, 
nign from malignant tumors. Forty-nine fibroadeno-
mas and 30 carcinomas with cytologic or histologic 
proof were identified. No significant difference was 
found between carcinomas and fibroadenomas when 
E arly detection of breast cancer has been corre-lated with improved survival rates. As small tumor size is one of the predictors of a good 
prognosis, attempts have been made to improve early 
detection methods. Palpation of a mass depends on a 
relatively large tumor size, is greatly influenced by the 
experience of the examiner, and does not yield defini-
tive information about the composition of the mass. 
Mammography has proved to be the best means of 
early detection of nonpalpable breast cancer, but it uses 
ionizing radiation and results in true-positive rates of 
only 80-85%. 1 Ultrasound is an important adjunct to 
mammography, its primary role being to distinguish 
cystic from solid masses.2-1 The gray-scale features of 
solid masses thus far have not proved to be sufficiently 
specific to allow differentiation of benign from malig-
nant solid masses.4" 8 
Previous sonographic descriptions of solid breast 
masses usually have been subjective evaluations of 
echogenicity, shape, and marginal features, without 
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comparing the average ratio of length to anteroposte-
rior (L/ AP) diameter or the mean ratio of anteropos-
terior diameter to transverse diameter (AP /T). In this 
limited series, quantification of the degree of mass 
elongation along the natural breast tissue planes had 
low sensitivity in distinguishing malignant from benign 
tumors. 
further quantification. To increase the predictive value 
of sonography in differentiating benign from malignant 
solid breast tumors, a limited number of recent reports 
have analyzed quantitative data,9- 11 suggesting that 
certain ratios of tumor length, width, and depth may 
provide improved sensitivity and specificity in distin-
guishing benign from malignant breast masses. Because 
such measurements might prove to be an important 
diagnostic and clinical aid, we performed a retrospec-
tive study of solid breast masses seen on sonography 
to determine whether such quantitative data could 
differentiate benign from malignant masses. 
PATIENTS AND METHODS 
Results of breast ultrasound examinations performed 
on women at the University of Michigan Hospitals 
between 1984 and 1990 were reviewed to identify 
patients with discrete solid tumors seen on sonography. 
Only tumors with correlative cytologic or histologic 
data were included. 
Seventy-five women with 79 solid breast masses 
were identified and are included in this series. Two 
women each had two discrete carcinomas occurring in 
the same breast, one woman had two fibroadenomas 
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in one breast, and another had bilateral fibroadenomas. 
The women ranged in age from 20 to 88 years (mean, 
52 years). Most tumors (70) were scanned using a 7.5 
MHz linear probe, Hitachi 310-EUB (Tokyo, Japan), 
whereas the remaining 9 masses were studied with a 5 
MHz linear transducer, Acuson 128 (Mountain View, 
CA). All ultrasound studies were performed prior to 
any invasive procedures. The length, anteroposterior 
(AP) diameter, and width were measured retrospec-
tively from the hard copy images by a method de-
scribed previously.9 The masses were also designated 
as having echogenicity Jess than (hypoechoic) or 
greater than (hyperechoic) the surrounding tissue. Also 
noted were location of the lesion in the breast, whether 
or not the mass was palpable, and visibility of the 
lesion on mammography. 
The only benign masses included in the study were 
those specifically diagnosed as fibroadenomas. All le-
sions were confirmed pathologically (58) or cytologi-
cally (21). Thirty masses proved to be malignant, 
whereas the remaining 49 were f:broadenomas. 
RESULTS 
Most masses were located in the upper outer quadrant 
(35%), 11 % were in the lower outer quadrant, and 14% 
were located in the outer positions of the breast (9 
o'clock right, 3 o'clock left). Fewer lesions were located 
in the inner regions of the breast: 14 % occurring in the 
upper inner quadrant, 8% in the lower inner quadrant, 
and 6% in the inner positions (3 o'clock right, 9 o'clock 
left). Eight percent of all lesions were found in the 12 
o'clock position, 2% were in the 6 o'clock position, and 
only 1 % were retroareolar. 
Sixty-one percent of the masses (48/ 79) were pal-
pable (24/49 fibroadenomas, 24/30 carcinomas), 
whereas the remaining 39% (31/79) were not Ninety 
percent (71/79) of all lesions could be seen on both 
mammography and ultrasound, but 10% (8/79) were 
visualized only by sonography, including one mass in 
a young (29 year old) woman who did not have a 
mammogram. All masses were hypoechoic. Eighty-six 
percent (42/49) of fibroadenomas and 97% (29/ 30) of 
cancers were visualized on mammography. 
The average length (L) of all the masses was 2.1 cm 
± 1.0 cm (range, 0.7- 5.0 cm). The average transverse 
(T) diameter was 2.0 cm ± 0.9 cm (range, 0.8- 4.9 cm), 
whereas the mean AP diameter was 1.1 cm ± 0.6 
(range, 0.4- 3.6 cm). The diameters for the fibroade-
nomas and carcinomas are summarized in Table 1. 
Calculated ratios included length-to-AP dimensions 
(L/ AP), and AP-to-transverse diameters (AP /T). The 
AP /T ratio has also been described previously as 
height-to-width ratio.9 The mean L/AP for all masses 
was 2.1 ± 0.8 (range, 0.7 to 4.0) and the mean AP/T 
was 0.6 ± 0.2 (range, 0.2 to 1.2). Ratios for the fibroad· 
enomas and carcinomas are listed in Table 2. 
DISCUSSION 
The value of ultrasound in distinguishing a cystic from 
a solid mass has been documented in numerous stud-
ies. 2•4 Sonographic differentiation of benign from ma-
lignant solid breast tumors generally has not been 
possible with a good degree of accuracy, mainly be-
cause of their overlap in gray· sca]e features.4...s Al-
though previous reports have focused on qualitative 
features to identify cancerous lesions on ultrasound, 
more recent studies attempt to utilize quantitative 
analysis of the sonographk data to allow differentia-
tion of malignant from benign masses.9- 11 
Some authors have suggested that the shape of 
benign and malignant lesions differs.5•9• 12 Fomage et 
Table 2: Comparison of Length/ 
Anteroposterior (L/ AP) and 
Anteroposterior/Transverse (AP /T) 
Ratios For Fibroadenomas and 
Carcinomas 
Fibroadenomas 
Carcinomas 
Range of Overlap 
Ratios 
L/ AP (SD) AP /T (SD) 
2.2 ± 0.8 
1.8 ;I: 0.6 
1.4- 2.4 
0.5 ± 0.2 
0.7 ± 0.2 
0.5- 0.7 
SD, Standard deviation . 
. Table 1: Comparison of Diameters of Fibroadenomas and Carcinomas 
Mean Diameter (cm) Standard Deviation (cm) Range (cm) 
Fibroadenomas (11 = 49) Length 1.9 ±0.7 0.7- 3.9 
Transverse 1.8 ±0.7 0.8- 4.3 
AP 0.9 ±0.3 0.4- 2.0 
Carcinomas (11 = 30) Length 2.5 ;t:l.2 0.8- 5.0 
Transverse 2.4 ±1.1 0.8- 4.9 
AP 1.5 ±0.8 0.4- 3.6 
AP, Anteroposterior. 
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al have postulated that fibroadenomas tend to be 
longer than they are deep because they grow along the 
breast's natural tissue planes.9' 10 These investigators 
compared L/ AP ratios for 49 carcinomas with those of 
a matched group of 49 fibroadenomas, all with a 
calculated volume less than 1 cm3 each. 10 They found 
that 61 3 of carcinomas had an L/ AP ratio less than or 
equal to 1.0, compared with only 43 of fibroadenomas. 
Nishimura et al stated that breast cancers appear 
smaller in width on ultrasound than their true size 
because the invasive component does not adequately 
reflect the ultrasonic waves and consequently is not 
seen on the sonographic image. 11 These investigators 
noted that owing to the nature of sonography and the 
structural characteristics of the carcinoma, the lesion 
also will appear smaller in the anteroposterior dimen-
sion, but to a lesser degree than for the width . Nishi-
mura et al found that the ratio of height to width (AP/ 
T) was greater for 68 malignant lesions than for 30 
unspecified benign lesions. 
In our own study group, we initially analyzed only 
those lesions (N = 25) with a volume less than 1 cm.3 
Using Fomage et al's initial assumption that an L/ AP 
ratio of less than 1.4 was indicative of cancer and that 
a ratio greater than 1.4 would likely represent a fibro-
adenoma,9 only 2 of 5 (40%) known cancers and 16 of 
20 (80%) known fibroadenomas would have been di-
agnosed correctly in our series. Thus, using the criterion 
stated earlier, the sensitivity for detecting cancer was 
40% and specificity was 803. If a value of 1.0 rather 
than 1.4 was used (as in a later study by Fomage et 
al), 10 the sensitivity for detection of carcinoma was 
zero. 
Because our preliminary data revealed no relation-
ship between the L/AP ratio of a lesion and its volume, 
we did not further restrict our study to lesions of a 
particular size. When considering all lesions, irrespec-
tive of volume, and using the threshold ratio of 1.4, 
we found that only 10/30 cancers (333) could be 
diagnosed correctly as malignant although 903 of 
fibroadenomas (44/49) could be diagnosed correctly as 
benign. The sensitivity and specificity for detecting 
cancer were 33% and 903, respectively. Using a cutoff 
of 1.0, the sensitivity and specificity were 33 and 983, 
respectively. Thus, although fibroadenomas tended to 
be longer than they were deep, the difference was not 
significant enough to allow benign and malignant le-
sions to be differentiated on the basis of the L/ AP ratio 
in our patients. 
To compare our data to that of Nishimura et al, 11 we 
calculated the AP/T ratio for all masses. Using the 
suggested ratio value of 0.8 or greater as a determinant 
of a malignant lesion, we would have diagnosed cor-
rectly only 10 of 30 (333) known cancers. Assuming 
that those lesions with a ratio of less than 0.8 were 
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benign, we were able to distinguish 46 of 49 (94%) 
known fibroadenomas as benign. In our patients, the 
sensitivity of this means of identifying cancer was 333, 
and the specificity was 943. Although our specificity 
is greater than the 703 specificity reported previously, 
our sensitivity was much less than the 723 sensitivity 
of Nishimura et al. 11 
The degree of error involved in obtaining the nu-
merical ratio limits the value of these classifications. 
The nature of the sonographic image resolution limits 
the specificity of the numerator and denominator each 
to ±1 mm. Because ultrasound examinations are highly 
operator dependent, such measurements may be erro-
neous if the lesion is not imaged along its largest 
diameter or if the transducer is not properly positioned 
in the longitudinal and transverse planes. The charac-
teristics of the lesions additionally introduce a degree 
of error if there is posterior shadowing and the lesion 
has irregular borders, as these make the lesions more 
difficult to measure. In our series, the variation intro-
duced in the actual measurement of the diameters was 
minimal, as all measurements were made by one 
viewer (DH). If, however, these measurements were to 
be recorded as standard practice in a clinical setting, 
variability would be introduced owing to subjective 
variation among viewers. When measuring lesions less 
than 1 cm in diameter, the error might be significant 
and, when further combined in a ratio, would result in 
an even larger degree of error. Consequently, if the 
standard use of ratios is to be of clinical value in 
distinguishing benign from malignant lesions, the ra-
tios would have to differ to a very large degree to 
compensate for the errors inherent in determining such 
ratios. 
Similar to the previous studies,9• 1° we found a slight 
tendency for the L/ AP ratio to be larger for fibroad-
enomas than for cancers. Analysis of the degree of 
anteroposterior growth compared to transverse elon-
gation for fibroadenomas showed an average that was 
slightly lower than for carcinomas. Unlike prior studies, 
however, our data indicated no significant difference 
in discriminating malignant from benign masses, even 
when comparing lesions of similar dimensions. Clas-
sifying solid masses on the basis of these ratios as 
benign or malignant resulted in low sensitivities. 
Our own study, as well as those cited previously, is 
limited by the relatively small number of lesions ex-
amined. Further investigations using larger numbers of 
benign and malignant breast masses may provide 
meaningful data. In conclusion, results from our patient 
population showed no significant difference between 
the L/ AP and AP /T ratios for fibroadenomas as com-
pared with carcinomas. The use of these ratios did not 
prove to be of additional value in the differentiation of 
benign from malignant solid breast tumors. 
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